img

Global Haemophilia Drug Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Haemophilia Drug Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Haemophilia Drug Market
The global Haemophilia Drug market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Haemophilia Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Haemophilia Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Haemophilia Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Haemophilia Drug include Bayer, Novo Nordisk, Pfizer, Roche, Baxter, Sinopharm, Shanghai Raas Blood Products, China Biologic Products and Hualan Bio, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Haemophilia Drug market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Haemophilia Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Haemophilia Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Haemophilia Drug revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Haemophilia Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Haemophilia Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer, Novo Nordisk, Pfizer, Roche, Baxter, Sinopharm, Shanghai Raas Blood Products, China Biologic Products and Hualan Bio, etc.



By Company


Bayer
Novo Nordisk
Pfizer
Roche
Baxter
Sinopharm
Shanghai Raas Blood Products
China Biologic Products
Hualan Bio
CGE Healthcare
Sinocelltech Group
Shanxi Kangbao Biological
CTTQ
Segment by Type
Coagulation Factor Therapy Drugs
Non-coagulation Factor Therapy Drugs

Segment by Application


Medical Institutions
Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Haemophilia Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Haemophilia Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Haemophilia Drug revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Haemophilia Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Coagulation Factor Therapy Drugs
1.2.3 Non-coagulation Factor Therapy Drugs
1.3 Market by Application
1.3.1 Global Haemophilia Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Medical Institutions
1.3.3 Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Haemophilia Drug Market Perspective (2018-2034)
2.2 Global Haemophilia Drug Growth Trends by Region
2.2.1 Haemophilia Drug Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Haemophilia Drug Historic Market Size by Region (2018-2024)
2.2.3 Haemophilia Drug Forecasted Market Size by Region (2024-2034)
2.3 Haemophilia Drug Market Dynamics
2.3.1 Haemophilia Drug Industry Trends
2.3.2 Haemophilia Drug Market Drivers
2.3.3 Haemophilia Drug Market Challenges
2.3.4 Haemophilia Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Haemophilia Drug by Players
3.1.1 Global Haemophilia Drug Revenue by Players (2018-2024)
3.1.2 Global Haemophilia Drug Revenue Market Share by Players (2018-2024)
3.2 Global Haemophilia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Haemophilia Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Haemophilia Drug Market Concentration Ratio
3.4.1 Global Haemophilia Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Haemophilia Drug Revenue in 2022
3.5 Global Key Players of Haemophilia Drug Head office and Area Served
3.6 Global Key Players of Haemophilia Drug, Product and Application
3.7 Global Key Players of Haemophilia Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Haemophilia Drug Breakdown Data by Type
4.1 Global Haemophilia Drug Historic Market Size by Type (2018-2024)
4.2 Global Haemophilia Drug Forecasted Market Size by Type (2024-2034)
5 Haemophilia Drug Breakdown Data by Application
5.1 Global Haemophilia Drug Historic Market Size by Application (2018-2024)
5.2 Global Haemophilia Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Haemophilia Drug Market Size (2018-2034)
6.2 North America Haemophilia Drug Market Size by Type
6.2.1 North America Haemophilia Drug Market Size by Type (2018-2024)
6.2.2 North America Haemophilia Drug Market Size by Type (2024-2034)
6.2.3 North America Haemophilia Drug Market Share by Type (2018-2034)
6.3 North America Haemophilia Drug Market Size by Application
6.3.1 North America Haemophilia Drug Market Size by Application (2018-2024)
6.3.2 North America Haemophilia Drug Market Size by Application (2024-2034)
6.3.3 North America Haemophilia Drug Market Share by Application (2018-2034)
6.4 North America Haemophilia Drug Market Size by Country
6.4.1 North America Haemophilia Drug Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Haemophilia Drug Market Size by Country (2018-2024)
6.4.3 North America Haemophilia Drug Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Haemophilia Drug Market Size (2018-2034)
7.2 Europe Haemophilia Drug Market Size by Type
7.2.1 Europe Haemophilia Drug Market Size by Type (2018-2024)
7.2.2 Europe Haemophilia Drug Market Size by Type (2024-2034)
7.2.3 Europe Haemophilia Drug Market Share by Type (2018-2034)
7.3 Europe Haemophilia Drug Market Size by Application
7.3.1 Europe Haemophilia Drug Market Size by Application (2018-2024)
7.3.2 Europe Haemophilia Drug Market Size by Application (2024-2034)
7.3.3 Europe Haemophilia Drug Market Share by Application (2018-2034)
7.4 Europe Haemophilia Drug Market Size by Country
7.4.1 Europe Haemophilia Drug Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Haemophilia Drug Market Size by Country (2018-2024)
7.4.3 Europe Haemophilia Drug Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Haemophilia Drug Market Size (2018-2034)
8.2 China Haemophilia Drug Market Size by Type
8.2.1 China Haemophilia Drug Market Size by Type (2018-2024)
8.2.2 China Haemophilia Drug Market Size by Type (2024-2034)
8.2.3 China Haemophilia Drug Market Share by Type (2018-2034)
8.3 China Haemophilia Drug Market Size by Application
8.3.1 China Haemophilia Drug Market Size by Application (2018-2024)
8.3.2 China Haemophilia Drug Market Size by Application (2024-2034)
8.3.3 China Haemophilia Drug Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Haemophilia Drug Market Size (2018-2034)
9.2 Asia Haemophilia Drug Market Size by Type
9.2.1 Asia Haemophilia Drug Market Size by Type (2018-2024)
9.2.2 Asia Haemophilia Drug Market Size by Type (2024-2034)
9.2.3 Asia Haemophilia Drug Market Share by Type (2018-2034)
9.3 Asia Haemophilia Drug Market Size by Application
9.3.1 Asia Haemophilia Drug Market Size by Application (2018-2024)
9.3.2 Asia Haemophilia Drug Market Size by Application (2024-2034)
9.3.3 Asia Haemophilia Drug Market Share by Application (2018-2034)
9.4 Asia Haemophilia Drug Market Size by Region
9.4.1 Asia Haemophilia Drug Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Haemophilia Drug Market Size by Region (2018-2024)
9.4.3 Asia Haemophilia Drug Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Haemophilia Drug Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Haemophilia Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Haemophilia Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Haemophilia Drug Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Haemophilia Drug Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Haemophilia Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Haemophilia Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Haemophilia Drug Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Haemophilia Drug Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Haemophilia Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Haemophilia Drug Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Haemophilia Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Haemophilia Drug Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Haemophilia Drug Introduction
11.1.4 Bayer Revenue in Haemophilia Drug Business (2018-2024)
11.1.5 Bayer Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Haemophilia Drug Introduction
11.2.4 Novo Nordisk Revenue in Haemophilia Drug Business (2018-2024)
11.2.5 Novo Nordisk Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Haemophilia Drug Introduction
11.3.4 Pfizer Revenue in Haemophilia Drug Business (2018-2024)
11.3.5 Pfizer Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Haemophilia Drug Introduction
11.4.4 Roche Revenue in Haemophilia Drug Business (2018-2024)
11.4.5 Roche Recent Developments
11.5 Baxter
11.5.1 Baxter Company Details
11.5.2 Baxter Business Overview
11.5.3 Baxter Haemophilia Drug Introduction
11.5.4 Baxter Revenue in Haemophilia Drug Business (2018-2024)
11.5.5 Baxter Recent Developments
11.6 Sinopharm
11.6.1 Sinopharm Company Details
11.6.2 Sinopharm Business Overview
11.6.3 Sinopharm Haemophilia Drug Introduction
11.6.4 Sinopharm Revenue in Haemophilia Drug Business (2018-2024)
11.6.5 Sinopharm Recent Developments
11.7 Shanghai Raas Blood Products
11.7.1 Shanghai Raas Blood Products Company Details
11.7.2 Shanghai Raas Blood Products Business Overview
11.7.3 Shanghai Raas Blood Products Haemophilia Drug Introduction
11.7.4 Shanghai Raas Blood Products Revenue in Haemophilia Drug Business (2018-2024)
11.7.5 Shanghai Raas Blood Products Recent Developments
11.8 China Biologic Products
11.8.1 China Biologic Products Company Details
11.8.2 China Biologic Products Business Overview
11.8.3 China Biologic Products Haemophilia Drug Introduction
11.8.4 China Biologic Products Revenue in Haemophilia Drug Business (2018-2024)
11.8.5 China Biologic Products Recent Developments
11.9 Hualan Bio
11.9.1 Hualan Bio Company Details
11.9.2 Hualan Bio Business Overview
11.9.3 Hualan Bio Haemophilia Drug Introduction
11.9.4 Hualan Bio Revenue in Haemophilia Drug Business (2018-2024)
11.9.5 Hualan Bio Recent Developments
11.10 CGE Healthcare
11.10.1 CGE Healthcare Company Details
11.10.2 CGE Healthcare Business Overview
11.10.3 CGE Healthcare Haemophilia Drug Introduction
11.10.4 CGE Healthcare Revenue in Haemophilia Drug Business (2018-2024)
11.10.5 CGE Healthcare Recent Developments
11.11 Sinocelltech Group
11.11.1 Sinocelltech Group Company Details
11.11.2 Sinocelltech Group Business Overview
11.11.3 Sinocelltech Group Haemophilia Drug Introduction
11.11.4 Sinocelltech Group Revenue in Haemophilia Drug Business (2018-2024)
11.11.5 Sinocelltech Group Recent Developments
11.12 Shanxi Kangbao Biological
11.12.1 Shanxi Kangbao Biological Company Details
11.12.2 Shanxi Kangbao Biological Business Overview
11.12.3 Shanxi Kangbao Biological Haemophilia Drug Introduction
11.12.4 Shanxi Kangbao Biological Revenue in Haemophilia Drug Business (2018-2024)
11.12.5 Shanxi Kangbao Biological Recent Developments
11.13 CTTQ
11.13.1 CTTQ Company Details
11.13.2 CTTQ Business Overview
11.13.3 CTTQ Haemophilia Drug Introduction
11.13.4 CTTQ Revenue in Haemophilia Drug Business (2018-2024)
11.13.5 CTTQ Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Haemophilia Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Coagulation Factor Therapy Drugs
Table 3. Key Players of Non-coagulation Factor Therapy Drugs
Table 4. Global Haemophilia Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 5. Global Haemophilia Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 6. Global Haemophilia Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Haemophilia Drug Market Share by Region (2018-2024)
Table 8. Global Haemophilia Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Haemophilia Drug Market Share by Region (2024-2034)
Table 10. Haemophilia Drug Market Trends
Table 11. Haemophilia Drug Market Drivers
Table 12. Haemophilia Drug Market Challenges
Table 13. Haemophilia Drug Market Restraints
Table 14. Global Haemophilia Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Haemophilia Drug Revenue Share by Players (2018-2024)
Table 16. Global Top Haemophilia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilia Drug as of 2022)
Table 17. Global Haemophilia Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Haemophilia Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Haemophilia Drug, Headquarters and Area Served
Table 20. Global Key Players of Haemophilia Drug, Product and Application
Table 21. Global Key Players of Haemophilia Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Haemophilia Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Haemophilia Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Haemophilia Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Haemophilia Drug Revenue Market Share by Type (2024-2034)
Table 27. Global Haemophilia Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Haemophilia Drug Revenue Share by Application (2018-2024)
Table 29. Global Haemophilia Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Haemophilia Drug Revenue Share by Application (2024-2034)
Table 31. North America Haemophilia Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Haemophilia Drug Market Size by Type (2024-2034) & (US$ Million)
Table 33. North America Haemophilia Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Haemophilia Drug Market Size by Application (2024-2034) & (US$ Million)
Table 35. North America Haemophilia Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 36. North America Haemophilia Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Haemophilia Drug Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe Haemophilia Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Haemophilia Drug Market Size by Type (2024-2034) & (US$ Million)
Table 40. Europe Haemophilia Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Haemophilia Drug Market Size by Application (2024-2034) & (US$ Million)
Table 42. Europe Haemophilia Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 43. Europe Haemophilia Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Haemophilia Drug Market Size by Country (2024-2034) & (US$ Million)
Table 45. China Haemophilia Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Haemophilia Drug Market Size by Type (2024-2034) & (US$ Million)
Table 47. China Haemophilia Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Haemophilia Drug Market Size by Application (2024-2034) & (US$ Million)
Table 49. Asia Haemophilia Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Haemophilia Drug Market Size by Type (2024-2034) & (US$ Million)
Table 51. Asia Haemophilia Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Haemophilia Drug Market Size by Application (2024-2034) & (US$ Million)
Table 53. Asia Haemophilia Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 54. Asia Haemophilia Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Haemophilia Drug Market Size by Region (2024-2034) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Haemophilia Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Haemophilia Drug Market Size by Type (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Haemophilia Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Haemophilia Drug Market Size by Application (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Haemophilia Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 61. Middle East, Africa, and Latin America Haemophilia Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Haemophilia Drug Market Size by Country (2024-2034) & (US$ Million)
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Haemophilia Drug Product
Table 66. Bayer Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 67. Bayer Recent Developments
Table 68. Novo Nordisk Company Details
Table 69. Novo Nordisk Business Overview
Table 70. Novo Nordisk Haemophilia Drug Product
Table 71. Novo Nordisk Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 72. Novo Nordisk Recent Developments
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Haemophilia Drug Product
Table 76. Pfizer Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 77. Pfizer Recent Developments
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Haemophilia Drug Product
Table 81. Roche Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 82. Roche Recent Developments
Table 83. Baxter Company Details
Table 84. Baxter Business Overview
Table 85. Baxter Haemophilia Drug Product
Table 86. Baxter Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 87. Baxter Recent Developments
Table 88. Sinopharm Company Details
Table 89. Sinopharm Business Overview
Table 90. Sinopharm Haemophilia Drug Product
Table 91. Sinopharm Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 92. Sinopharm Recent Developments
Table 93. Shanghai Raas Blood Products Company Details
Table 94. Shanghai Raas Blood Products Business Overview
Table 95. Shanghai Raas Blood Products Haemophilia Drug Product
Table 96. Shanghai Raas Blood Products Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 97. Shanghai Raas Blood Products Recent Developments
Table 98. China Biologic Products Company Details
Table 99. China Biologic Products Business Overview
Table 100. China Biologic Products Haemophilia Drug Product
Table 101. China Biologic Products Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 102. China Biologic Products Recent Developments
Table 103. Hualan Bio Company Details
Table 104. Hualan Bio Business Overview
Table 105. Hualan Bio Haemophilia Drug Product
Table 106. Hualan Bio Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 107. Hualan Bio Recent Developments
Table 108. CGE Healthcare Company Details
Table 109. CGE Healthcare Business Overview
Table 110. CGE Healthcare Haemophilia Drug Product
Table 111. CGE Healthcare Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 112. CGE Healthcare Recent Developments
Table 113. Sinocelltech Group Company Details
Table 114. Sinocelltech Group Business Overview
Table 115. Sinocelltech Group Haemophilia Drug Product
Table 116. Sinocelltech Group Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 117. Sinocelltech Group Recent Developments
Table 118. Shanxi Kangbao Biological Company Details
Table 119. Shanxi Kangbao Biological Business Overview
Table 120. Shanxi Kangbao Biological Haemophilia Drug Product
Table 121. Shanxi Kangbao Biological Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 122. Shanxi Kangbao Biological Recent Developments
Table 123. CTTQ Company Details
Table 124. CTTQ Business Overview
Table 125. CTTQ Haemophilia Drug Product
Table 126. CTTQ Revenue in Haemophilia Drug Business (2018-2024) & (US$ Million)
Table 127. CTTQ Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Haemophilia Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Haemophilia Drug Market Share by Type: 2022 VS 2034
Figure 3. Coagulation Factor Therapy Drugs Features
Figure 4. Non-coagulation Factor Therapy Drugs Features
Figure 5. Global Haemophilia Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 6. Global Haemophilia Drug Market Share by Application: 2022 VS 2034
Figure 7. Medical Institutions Case Studies
Figure 8. Pharmacies Case Studies
Figure 9. Haemophilia Drug Report Years Considered
Figure 10. Global Haemophilia Drug Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 11. Global Haemophilia Drug Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Haemophilia Drug Market Share by Region: 2022 VS 2034
Figure 13. Global Haemophilia Drug Market Share by Players in 2022
Figure 14. Global Top Haemophilia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilia Drug as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Haemophilia Drug Revenue in 2022
Figure 16. North America Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 17. North America Haemophilia Drug Market Share by Type (2018-2034)
Figure 18. North America Haemophilia Drug Market Share by Application (2018-2034)
Figure 19. North America Haemophilia Drug Market Share by Country (2018-2034)
Figure 20. United States Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Haemophilia Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 23. Europe Haemophilia Drug Market Share by Type (2018-2034)
Figure 24. Europe Haemophilia Drug Market Share by Application (2018-2034)
Figure 25. Europe Haemophilia Drug Market Share by Country (2018-2034)
Figure 26. Germany Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. China Haemophilia Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 33. China Haemophilia Drug Market Share by Type (2018-2034)
Figure 34. China Haemophilia Drug Market Share by Application (2018-2034)
Figure 35. Asia Haemophilia Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 36. Asia Haemophilia Drug Market Share by Type (2018-2034)
Figure 37. Asia Haemophilia Drug Market Share by Application (2018-2034)
Figure 38. Asia Haemophilia Drug Market Share by Region (2018-2034)
Figure 39. Japan Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. South Korea Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. China Taiwan Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Southeast Asia Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. India Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Australia Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Haemophilia Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Haemophilia Drug Market Share by Type (2018-2034)
Figure 47. Middle East, Africa, and Latin America Haemophilia Drug Market Share by Application (2018-2034)
Figure 48. Middle East, Africa, and Latin America Haemophilia Drug Market Share by Country (2018-2034)
Figure 49. Brazil Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Mexico Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Turkey Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Israel Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. GCC Countries Haemophilia Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Bayer Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 56. Novo Nordisk Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 57. Pfizer Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 58. Roche Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 59. Baxter Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 60. Sinopharm Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 61. Shanghai Raas Blood Products Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 62. China Biologic Products Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 63. Hualan Bio Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 64. CGE Healthcare Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 65. Sinocelltech Group Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 66. Shanxi Kangbao Biological Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 67. CTTQ Revenue Growth Rate in Haemophilia Drug Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed